208 related articles for article (PubMed ID: 32928212)
1. In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors.
Ploypetch S; Roytrakul S; Phaonakrop N; Kittisenachai S; Leetanasaksakul K; Pisamai S; Kalpravidh C; Rungsipipat A; Suriyaphol G
BMC Vet Res; 2020 Sep; 16(1):335. PubMed ID: 32928212
[TBL] [Abstract][Full Text] [Related]
2. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches.
Pisamai S; Roytrakul S; Phaonakrop N; Jaresitthikunchai J; Suriyaphol G
PLoS One; 2018; 13(7):e0200619. PubMed ID: 30001383
[TBL] [Abstract][Full Text] [Related]
4. Salivary Proteomic Analysis of Canine Oral Melanoma by MALDI-TOF Mass Spectrometry and LC-Mass Spectrometry/Mass Spectrometry.
Ploypetch S; Roytrakul S; Suriyaphol G
Methods Mol Biol; 2021; 2265():429-445. PubMed ID: 33704732
[TBL] [Abstract][Full Text] [Related]
5. Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors.
Ploypetch S; Jaresitthikunchai J; Phaonakrop N; Sakcamduang W; Manee-In S; Suriyaphol P; Roytrakul S; Suriyaphol G
Sci Rep; 2022 Dec; 12(1):21641. PubMed ID: 36517562
[TBL] [Abstract][Full Text] [Related]
6. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
7. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
[TBL] [Abstract][Full Text] [Related]
8. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
10. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
11. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
12. Tissue transcriptome profiling and pathway analyses revealed novel potential biomarkers in the tumor progression of canine oral melanoma.
Pisamai S; Edwards SW; Cheng CW; Chaivichit P; Sooksiri M; Yanakam S; Maneewong S; Suriyaphol G
Res Vet Sci; 2023 Dec; 165():105036. PubMed ID: 37856944
[TBL] [Abstract][Full Text] [Related]
13. Identification of volatile metabolites in human saliva from patients with oral squamous cell carcinoma via zeolite-based thin-film microextraction coupled with GC-MS.
Shigeyama H; Wang T; Ichinose M; Ansai T; Lee SW
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():49-58. PubMed ID: 30445287
[TBL] [Abstract][Full Text] [Related]
14. Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.
Kawabe M; Baba Y; Tamai R; Yamamoto R; Komori M; Mori T; Takenaka S
J Vet Med Sci; 2015 Aug; 77(8):1025-8. PubMed ID: 25843037
[TBL] [Abstract][Full Text] [Related]
15. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
16. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.
Jancsik VA; Gelencser G; Maasz G; Schmidt J; Molnar GA; Wittmann I; Olasz L; Mark L
Pathol Oncol Res; 2014 Jul; 20(3):591-5. PubMed ID: 24343817
[TBL] [Abstract][Full Text] [Related]
17. Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry.
Chu HW; Chang KP; Yen WC; Liu HP; Chan XY; Liu CR; Hung CM; Wu CC
Proteomics; 2023 May; 23(9):e2200321. PubMed ID: 36625099
[TBL] [Abstract][Full Text] [Related]
18. Salivary proteomics for oral cancer biomarker discovery.
Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
[TBL] [Abstract][Full Text] [Related]
20. Salivary proteomics in monitoring the therapeutic response of canine oral melanoma.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Teewasutrakul P; Rungsipipat A; Suriyaphol G
PLoS One; 2021; 16(8):e0256167. PubMed ID: 34411146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
